PortfoliosLab logo

Allogene Therapeutics, Inc. (ALLO)

Equity · Currency in USD · Last updated Sep 17, 2022

Company Info

ISINUS0197701065
CUSIP019770106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$13.67
Year Range$6.78 - $27.64
EMA (50)$13.81
EMA (200)$13.93
Average Volume$1.54M
Market Capitalization$2.01B

ALLOShare Price Chart


Chart placeholderClick Calculate to get results

ALLOPerformance

The chart shows the growth of $10,000 invested in Allogene Therapeutics, Inc. in Oct 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,468 for a total return of roughly -45.32%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%AprilMayJuneJulyAugustSeptember
37.25%
-14.15%
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-17.55%-10.03%
6M51.89%-12.20%
YTD-8.38%-18.73%
1Y-45.32%-13.56%
5Y-14.26%9.34%
10Y-14.26%9.34%

ALLOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-23.26%-20.09%-0.44%-8.34%-5.03%43.76%13.86%5.62%-0.29%
202137.48%0.03%1.70%-12.41%-16.88%1.48%-15.84%8.66%7.76%-32.92%7.25%-19.31%
2020-16.40%24.31%-28.00%48.66%66.64%-11.09%-14.36%-2.78%5.78%-10.05%-8.46%-18.71%
201912.63%4.48%-8.77%3.60%-12.42%2.36%15.46%-12.16%0.09%5.67%-2.15%-7.81%
2018-3.96%30.28%-13.91%

ALLOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Allogene Therapeutics, Inc. Sharpe ratio is -0.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.48
-0.62
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLODividend History


Allogene Therapeutics, Inc. doesn't pay dividends

ALLODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-74.70%
-19.25%
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLOWorst Drawdowns

The table below shows the maximum drawdowns of the Allogene Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Allogene Therapeutics, Inc. is 87.45%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.45%May 26, 2020496May 11, 2022
-45.29%Nov 7, 2018341Mar 18, 202037May 11, 2020378
-16.54%Oct 16, 20187Oct 24, 20187Nov 2, 201814
-7.25%May 12, 20202May 13, 20201May 14, 20203
-0.39%May 19, 20201May 19, 20201May 20, 20202

ALLOVolatility Chart

Current Allogene Therapeutics, Inc. volatility is 66.31%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%AprilMayJuneJulyAugustSeptember
66.31%
30.01%
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)